We're expecting very high temperatures in London over the next couple of days, and fundraising in biotech is just as hot. Ollin announced its $330 million Series B today, and RQ Bio has a $115 million Series A. There's also Osanni's Series B worth $190 million. We'll be tracking if the momentum continues.